Citations

Mayo Clinic

Clear

818 citation(s) found for "Kääb, Stefan".

Precisely Wrong? Urinary Fractionated Metanephrines and Peer-Based Laboratory Proficiency Testing
Grebe, Stefan K. , Yue, Bingfang, Rockwood, Alan L. , Cramer, John C., Gombos, Zoltán , Eisenhofer, Graeme , Singh, Ravinder

Clinical Chemistry | January 29, 2005 | Volume: 51 | Issue: 2 | Pages: 472-474

10.1373/clinchem.2004.043802 | PMID 15681566 Get It

PPARγ Staining as a Surrogate for PAX8/PPARγ Fusion Oncogene Expression in Follicular Neoplasms: Clinicopathological Correlation and Histopathological Diagnostic Value
Şahi̇n, Mustafa , Allard, Brandon L., Yates, Martin T. , Powell, J. Gregory, Wang, Xiao-Li, Zhao, Ying , Goellner, John R., Sebo, Thomas J., Grebe, Stefan K., Eberhardt, Norman L., McIver, Bryan, Wang, Xiao-Li, Hay, Ian

The Journal of Clinical Endocrinology & Metabolism | January 10, 2005 | Volume: 90 | Issue: 1 | Pages: 463-468

10.1210/jc.2004-1203 | PMID 15483076 Get It

Abstract The PAX8/PPARγ (PPFP) fusion-oncogene is moderately specific for follicular thyroid carcinomas (FTC). It remains unknown whether this can be translated into improved diagnosis, classification, or outcome prediction. We studied a cohort of well-characterized follicular adenomas (FA), FTC, and Hürthle cell carcinomas (HCC) from patients with complete clinical follow-up, to determine whether PPARγ immunohistochemistry (as a surrogate of PAX8/PPARγ expression) helps to distinguish FA from FTC and to assess its diagnostic accuracy as an adjunct to frozen section. We also correlated PPARγ staining with clinical outcomes to assess its role as a prognostic marker. PPARγ staining was more common in FTC (31 of 54; 57%) than in HCC (one of 23; 4%) or FA (four of 31; 13%) (P < 0.000001). Adjunctive use of PPARγ immunohistochemistry improved diagnostic sensitivity of intraoperative frozen section from 84% to 96% (P < 0.05) but reduced specificity from 100% to 90% (P < 0.05). PPARγ staining was associated with favorable prognostic indicators (female gender, better tumor differentiation, and lesser risk of metastases). PPARγ staining may be helpful in the differential diagnosis of FA, FTC, and HCC, particularly when diagnostic sensitivity of histomorphology is reduced (e.g. during intraoperative frozen section). PPARγ staining also shows an association with favorable prognosis and may have a role in risk stratification.
Prevalence of Heterophilic Antibody Interference in Eight Automated Tumor Marker Immunoassays
Preissner, Carol M., Dodge, Larry A., O’Kane, Dennis J., Grebe, Stefan K., Singh, Ravinder J.

Clinical Chemistry | December 22, 2004 | Volume: 51 | Issue: 1 | Pages: 208-210

10.1373/clinchem.2004.040501 | PMID 15613712 Get It

Development and Validation of an Automated Chemiluminometric Immunoassay for Human Intrinsic Factor Antibodies in Serum
Gomez, Elizabeth A., Ehresmann, Daniel D., Ledebuhr, Lisa K, Eastvold, Mary L., Klee, George G., Grebe, Stefan K., Singh, Ravinder J.

Clinical Chemistry | December 22, 2004 | Volume: 51 | Issue: 1 | Pages: 232-235

10.1373/clinchem.2004.043133 | PMID 15613720 Get It

Malignant pheochromocytoma: current status and initiatives for future progress
Eisenhofer, Graeme , Bornstein, Stefan R. , Brouwers, Frederieke M., Cheung, Nai‐Kong V. , Giordano, Thomas J. , Lehnert, Hendrik, Manger, William M., Neumann, Hartmut P.H., Pacák, Karel , Shulkin, Barry L. , Smith, David I, Tischler, Arthur S. , Dahia, Patricia L. M. , Krijger, Ronald R. de , Greene, Lloyd A. , Goldstein, David S. , Maris, John M. , Smith, David I, Young, William F. , Shulkin, Barry L

Endocrine-Related Cancer | December 2, 2004 | Volume: 11 | Issue: 3 | Pages: 423-436

10.1677/erc.1.00829 | PMID 15369446 Get It

Abstract Pheochromocytomas are rare catecholamine-producing neuroendocrine tumors that are usually benign, but which may also present as or develop into a malignancy. Predicting such behavior is notoriously difficult and there are currently no curative treatments for malignant tumors. This report follows from a workshop at the Banbury Conference Center, Cold Spring Harbor, New York, on the 16th–18th November 2003, held to review the state of science and to facilitate future progress in the diagnosis and treatment of malignant pheochromocytoma. The rarity of the tumor and the resulting fragmented nature of studies, typically involving small numbers of patients, represent limiting factors to the development of effective treatments and diagnostic or prognostic markers for malignant disease. Such development is being facilitated by the availability of new genomics-based tools, but for such approaches to succeed ultimately requires comprehensive clinical studies involving large numbers of patients, stringently collected clinical data and tumor samples, and interdisciplinary collaborations among multiple specialist centers. Nevertheless, the well-characterized hereditary basis and the unique functional nature of these neuroendocrine tumors provide a useful framework that offers advantages for establishing the pathways of tumorigenesis and malignancy. Such findings may have relevance for understanding the basis of other more common malignancies where similar frameworks are not available. As the relevant pathways leading to pheochromocytoma are established it should be possible to take advantage of the new generation of drugs being developed to target specific pathways in other malignancies. Again the success of this will require well-designed and coordinated multicenter studies.
Quantitative, Highly Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Detection of Synthetic Corticosteroids
Grebe, Stefan K., Taylor, Robert L. , Singh, Ravinder J.

Clinical Chemistry | October 15, 2004 | Volume: 50 | Issue: 12 | Pages: 2345-2352

10.1373/clinchem.2004.033605 | PMID 15486026 Get It

Abstract Background: Measurements of serum or urine concentrations of synthetic glucocorticoids are useful for assessing suspected iatrogenic hypothalamic-pituitary-adrenal axis suppression and Cushing syndrome. We have developed a liquid chromatography–tandem mass spectrometry (LC-MS/MS) assay for the simultaneous quantitative analysis of beclomethasone dipropionate, betamethasone, budesonide, dexamethasone, fludrocortisone, flunisolide, fluorometholone, fluticasone propionate, megestrol acetate, methylprednisolone, prednisolone, prednisone, triamcinolone, and triamcinolone acetonide. Methods: Stable isotopes of cortisol-9,11,12,12-d4 and triamcinolone-d1 acetonide-d6 were added as internal standards to calibrators, controls, and unknown samples. After acetonitrile precipitation, these samples were extracted with methylene chloride, and the extracts were washed and dried. Reconstituted extract (15 μL) was injected on a reversed-phase column and analyzed by LC-MS/MS in positive-ion mode. Assay precision, accuracy, linearity, and sample stability were determined by use of enriched samples. Clinical validation included analysis of 8 serum and 20 urine samples from patients with undetectable cortisol concentrations and analysis of different types of tablets. Results: Functional assay sensitivity was as low as 0.6–1.6 nmol/L for all compounds except for triamcinolone (7.6 nmol/L). Interassay CVs were 3.0–20% for concentrations of 0.6–364 nmol/L for all analytes. Recoveries of all analytes (except triamcinolone in serum) were 82–138% at 19.2–693 nmol/L. All but one of the serum and urine samples from patients who were tested because of suppressed cortisol concentrations contained at least one synthetic steroid. Tablet analysis recovered 75% of the synthetic steroids in suspected drugs. Conclusions: LC-MS/MS allows simultaneous quantitative detection of various synthetic steroids in serum, plasma, urine, and tablets. This provides a valuable tool for evaluating the clinical effects of topical and systemic synthetic corticosteroids.
Differential Effects of Theophylline on Sympathetic Excitation, Hemodynamics, and Breathing in Congestive Heart Failure
Reiter, Hartwig, Lüthje, Lars , Delekat, André, Grunewald, R. Willi, Andreas, Stefan , Hasenfuß, Gerd , Somers, Virend K.

Circulation | October 5, 2004 | Volume: 110 | Issue: 15 | Pages: 2157-2162

10.1161/01.cir.0000144356.39262.16 | PMID 15466632 Get It

Background— Patients with heart failure have high levels of central sympathetic outflow and also have a high prevalence of sleep-related breathing disorders, predominantly central sleep apnea. The options for treating central sleep apnea in heart failure are limited and include theophylline. Whether theophylline alters sympathetic activity in heart failure patients is not known. Methods and Results— Using a single-blinded, randomized, placebo-controlled study design, we investigated the sympathetic, hemodynamic, neurohumoral, and ventilatory effects of theophylline in patients with congestive heart failure compared with healthy control subjects closely matched for age, sex, and body mass index. Theophylline increased muscle sympathetic nerve activity and lowered transcutaneous CO 2 in the control subjects but only lowered transcutaneous CO 2 in the heart failure patients. Theophylline nearly doubled plasma renin concentration in both the healthy subjects ( P <0.01) and the heart failure patients ( P <0.02). Conclusions— Our study shows that in heart failure patients, there are differential effects of theophylline: in contrast to healthy subjects, theophylline does not increase sympathetic activity in heart failure, whereas increases in plasma renin and ventilation are still evident. These novel findings may have important implications for understanding the potential harmful and beneficial effects of theophylline and related substances in heart failure patients.
DNA microarray analysis of gene expression in alveolar epithelial cells in response to TNFα, LPS, and cyclic stretch
Santos, Claúdia C. dos , Han, Bing , Andrade, C , Uhlig, Stefan , Hubmayr, Rolf D., Tsang, Melanie E. , Lodyga, Monika , Keshavjee, Shaf , Slutsky, Arthur S. , Liu, Mingyao , Bai, Xiaohui

Physiological Genomics | September 29, 2004 | Volume: 19 | Issue: 3 | Pages: 331-342

10.1152/physiolgenomics.00153.2004 | PMID 15454581 Get It

Recent evidence suggests that alveolar epithelial cells (AECs) may contribute to the development, propagation, and resolution of acute lung injury (ALI)/acute respiratory distress syndrome (ARDS). Proinflammatory cytokines, pathogen products, and injurious mechanical ventilation are important contributors of excessive inflammatory responses in the lung. In the present study, we used cDNA microarrays to define the gene expression patterns of A549 cells (an AEC line) in the early stages of three models of pulmonary parenchymal cell activation: cells treated with tumor necrosis factor-α (TNFα) (20 ng/ml), lipopolysaccharide (LPS, 1 μg/ml), or cyclic stretch (20% elongation) for either 1 h or 4 h. Differential gene expression profiles were determined by gene array analysis. TNFα induced an inflammatory response pattern, including induction of genes for chemokines, inflammatory mediators, and cell surface membrane proteins. TNFα also increased genes related to pro- and anti-apoptotic proteins, signal transduction proteins, and transcriptional factors. TNFα further induced a group of genes that may form a negative feedback loop to silence the NFκB pathway. Stimulation of AECs with mechanical stretch changed cell morphology and activated Src protein tyrosine kinase. The combination of TNFα plus stretch enhanced or attenuated expression of multiple genes. LPS decreased microfilament polymerization but had less impact on NFκB translocation and gene expression. Results from this study indicate that AECs can tailor their response to different stimuli or/and combination of stimuli and subsequently play an important role in acute inflammatory responses in the lung.
Plastic versus Glass Tubes: Effects on Analytical Performance of Selected Serum and Plasma Hormone Assays
Preissner, Carol M., Reilly, William M., Cyr, Richard C, O’Kane, Dennis J., Grebe, Stefan K., Singh, Ravinder

Clinical Chemistry | June 30, 2004 | Volume: 50 | Issue: 7 | Pages: 1245-1247

10.1373/clinchem.2004.034108 | PMID 15229156 Get It

Substitution of 3′-Phosphate Cap with a Carbon-Based Blocker Reduces the Possibility of Fluorescence Resonance Energy Transfer Probe Failure in Real-Time PCR Assays
Cradic, Kendall W, Wells, Jason E. , Kruckeberg, Kent E., Grebe, Stefan K., Allen, Lindsay H. , Singh, Ravinder

Clinical Chemistry | May 25, 2004 | Volume: 50 | Issue: 6 | Pages: 1080-1082

10.1373/clinchem.2004.033183 | PMID 15161729 Get It